dc.contributor.author | Prichard, Kate L | |
dc.contributor.author | O'Brien, Nicholas | |
dc.contributor.author | Ghorbani, Mahdi | |
dc.contributor.author | Wood, Adam | |
dc.contributor.author | Barnes, Evan | |
dc.contributor.author | Kato, Atsushi | |
dc.contributor.author | Houston, Todd A | |
dc.contributor.author | Simone, Michela I | |
dc.date.accessioned | 2019-06-24T01:57:40Z | |
dc.date.available | 2019-06-24T01:57:40Z | |
dc.date.issued | 2018 | |
dc.identifier.issn | 1434-193X | |
dc.identifier.doi | 10.1002/ejoc.201801011 | |
dc.identifier.uri | http://hdl.handle.net/10072/385740 | |
dc.description.abstract | Stereoselective and biocatalysed synthetic routes to 3,4,5‐trihydroxypiperidines and their N‐ and O‐derivatisations are reviewed. These iminosugars effectively modulate glycosidase enzymes and display biological activities in immunosuppression, as anti‐inflammatory agents and as anti‐viral agents. Syntheses to these building blocks and their N‐ and O‐derivatives are predicted to produce drug leads of high Fsp3 index. This is also crucial in the collection of structure‐activity relationship data, particularly for diseases dependant on glycosidase modulation. | |
dc.description.peerreviewed | Yes | |
dc.language | English | |
dc.language.iso | eng | |
dc.publisher | WILEY | |
dc.relation.ispartofpagefrom | 6830 | |
dc.relation.ispartofpageto | 6842 | |
dc.relation.ispartofissue | 48 | |
dc.relation.ispartofjournal | EUROPEAN JOURNAL OF ORGANIC CHEMISTRY | |
dc.subject.fieldofresearch | Medicinal and biomolecular chemistry | |
dc.subject.fieldofresearch | Organic chemistry | |
dc.subject.fieldofresearchcode | 3404 | |
dc.subject.fieldofresearchcode | 3405 | |
dc.title | Synthetic Routes to 3,4,5-Trihydroxypiperidines via Stereoselective and Biocatalysed Protocols, and Strategies to N- and O-Derivatisation | |
dc.type | Journal article | |
dc.type.description | C1 - Articles | |
dc.type.code | C - Journal Articles | |
gro.hasfulltext | No Full Text | |
gro.griffith.author | Houston, Todd A. | |